Results 21 to 30 of about 6,860 (229)

Extrarenal complications of cystinosis

open access: yesPediatric nephrology (Berlin, West), 2023
Cystinosis is a rare autosomal recessive disease with an incidence 1 per 100,000–200,000 live births. It is caused by pathogenic variants of the cystinosin (CTNS) gene that lead to impaired cystine transport from lysosomes to cystosol, resulting in ...
R. Topaloğlu
semanticscholar   +2 more sources

Emerging therapeutic strategies for cystinosis. [PDF]

open access: yesFront Pediatr
For over 40 years, oral cysteamine has been the mainstay of therapy for cystinosis. While it has been of great benefit, slowing organ deterioration and prolonging life, cysteamine is not well tolerated and may not rescue all pathogenic mechanisms driving
Goodyer P, Torban E.
europepmc   +4 more sources

Unveiling cystinosis in India

open access: yesJournal of Rare Diseases
Background Cystinosis, a rare autosomal recessive disease, stems from genetic alterations in the CTNS gene, leading to a malfunction of lysosomal ‘cystinosin’ protein.
Aniruddh Heroor   +4 more
doaj   +2 more sources

Cystinosis: a review [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2016
Cystinosis is the most common hereditary cause of renal Fanconi syndrome in children. It is an autosomal recessive lysosomal storage disorder caused by mutations in the CTNS gene encoding for the carrier protein cystinosin, transporting cystine out of the lysosomal compartment. Defective cystinosin function leads to intra-lysosomal cystine accumulation
Ibrahim, Mohamed   +5 more
openaire   +5 more sources

Biomarkers in Nephropathic Cystinosis: Current and Future Perspectives

open access: yesCells, 2022
Early diagnosis and effective therapy are essential for improving the overall prognosis and quality of life of patients with nephropathic cystinosis. The severity of kidney dysfunction and the multi-organ involvement as a consequence of the increased ...
F. Emma   +9 more
semanticscholar   +2 more sources

Health‐related quality of life and patient‐reported outcome measurements in patients with cystinosis

open access: yesJIMD Reports, 2023
Nephropathic cystinosis is a rare autosomal recessive lysosomal storage disorder. With the availability of treatment and renal replacement therapy, nephropathic cystinosis has evolved from an early fatal disease to a chronic, progressive disorder with ...
Stefanie Witt   +3 more
doaj   +2 more sources

Nephropathic Cystinosis: Symptoms, Treatment, and Perspectives of a Systemic Disease

open access: yesFrontiers in Pediatrics, 2018
Cystinosis is a rare autosomal recessive lysosomal storage disorder caused by mutations in the CTNS gene. Main dysfunction is a defective clearance of cystine from lysosomes that leads to accumulation of cystine crystals in every tissue of the body ...
Sören Bäumner, Lutz T. Weber
doaj   +2 more sources

Nephropathic Cystinosis : First reported case in Oman

open access: yesSultan Qaboos University Medical Journal, 2011
Cystinosis is an autosomal recessive, lysosomal storage disease characterised by the accumulation of the amino acid cystine in different organs and tissues. It is a multisystemic disease that can present with renal and extra renal manifestations.
Dana Al-Nabhani   +5 more
doaj   +2 more sources

A different approach to cystinosis: ultrasound, doppler, and shear wave elastography findings of thyroid gland

open access: yesOrphanet Journal of Rare Diseases, 2023
Background While thyroid dysfunction develops in about 50% of untreated children with cystinosis, there is no data about how the sonography of thyroid tissue appears in this disease.
Derya Bako   +4 more
doaj   +2 more sources

Untangling Traffic Jams: RAB11FIP4 Orchestrates Cellular Recovery in Cystinosis [PDF]

open access: yesAutophagy Reports
RAB11FIP4 (RAB11 family interacting protein 4), a RAB11A (Ras-related protein Rab-11) effector protein downregulated in cystinosis, plays a crucial role in cellular trafficking.
Mouad Ait Kbaich   +2 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy